



Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
Information about Metamucil Therapy for Regularity, a fiber laxative made by The Procter & Gamble Manufacturing Company using psyllium husk. details on the active ingredient, dosage instructions, warnings, and side effects. It also mentions the product's uses and benefits, such as helping maintain healthy blood sugar levels and promoting heart health.
Typology: Schemes and Mind Maps
1 / 5
This page cannot be seen from the preview
Don't miss anything!
METAMUCIL THERAPY FOR REGULARITY- psyllium husk powder The Procter & Gamble Manufacturing Company Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Metamucil Therapy for Regularity Drug Facts Active ingredient (in each TABLESPOON) Psyllium husk approximately 3.4 g Purpose Fiber laxative Uses for relief of occasional constipation (irregularity). This product generally produces bowel movement in 12 to 72 hours. Choking Taking this product without adequate fluid may cause it to swell and block your throat or esophagus andmay cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention. Allergy alert This product may cause allergic reaction in people sensitive to inhaled or ingested psyllium. Ask a doctor before use if you have a sudden change in bowel habits persisting for 2 weeks abdominal pain, nausea or vomiting Stop use and ask a doctor if
Control Center right away. Directions Put one dose into an empty glass.Mix this product (child or adult dose) with at least 8 ounces (a full glass) of water or other fluid. Stir briskly and drink promptly. If mixture thickens, add more liquid and stir. For a lighter flavor experience and thinner drink, use more water. Adults 12 yrs. & older 1 packet in 8 oz of liquid at the first sign of irregularity. Can be taken up to 3 times daily. 6 – 11 yrs. 1/2 packet in 8 oz of liquid, up to 3 times daily Under 6 yrs. Consult a doctor As your body adjusts to increased fiber intake, you may experience changes in bowel habits or minor bloating. New Users: Start with 1 dose per day; gradually increase to 3 doses per day as necessary. New Users Start with 1 dose per day; gradually increase to 3 doses per day as necessary. Other information
**- each packet contains: potassium35 mg; sodium5 mg
psyllium husk powder Product Information Product Type HUMAN OTC DRUG^ Item Code (Source) NDC:37000- Route of Administration ORAL
The Procter & Gamble Manufacturing Company Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PSYLLIUM HUSK (UNII: 0SHO53407G) (PSYLLIUM HUSK - UNII:0SHO53407G) PSYLLIUM HUSK 3.4 g in 12 g Inactive Ingredients Ingredient Name Strength CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) FD&C YELLOW NO. 6 (UNII: H77VEI93A8) SUCROSE (UNII: C151H8M554) Product Characteristics Color brown^ Score Shape Size Flavor ORANGE^ **Imprint Code Contains Packaging
Date Marketing End Date 1** NDC:37000-023- 06 822 g in 1 CANISTER; Type 0: Not a Combination Product 03/31/ 2 NDC:37000-023- 05 575 g in 1 CANISTER; Type 0: Not a Combination Product 03/31/ 3 NDC:37000-023- 04 30 in 1 CARTON 03/31/ 3 NDC:37000-023- 10 12 g in 1 POUCH; Type 0: Not a Combination Product 4 NDC:37000-023- 10 12 g in 1 POUCH; Type 0: Not a Combination Product 03/31/
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part334^ 03/31/
Revised: 11/